Cancer Biomarkers in Body Fluids 2016
DOI: 10.1007/978-3-319-01580-4_4
|View full text |Cite
|
Sign up to set email alerts
|

Methylated DNA as Cancer Biomarkers in Circulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…It can be served as non-invasive early diagnostic tool to detect cervical cancer. Different stages of cervical carcinogenesis can be represented by different methylation pattern of tumour suppressor genes in serum as well as in tissue samples ( 88 , 89 ). Single epigenetic biomarkers are not adequately sensitive to predict oncogenic progression, thus panels of candidate genes can improve sensitivity.…”
Section: Epigenetic Biomarkers In Clinical Applicationsmentioning
confidence: 99%
“…It can be served as non-invasive early diagnostic tool to detect cervical cancer. Different stages of cervical carcinogenesis can be represented by different methylation pattern of tumour suppressor genes in serum as well as in tissue samples ( 88 , 89 ). Single epigenetic biomarkers are not adequately sensitive to predict oncogenic progression, thus panels of candidate genes can improve sensitivity.…”
Section: Epigenetic Biomarkers In Clinical Applicationsmentioning
confidence: 99%